Endothelial progenitor cells (EPCs) derived from bone marrow and blood can differentiate
into endothelial cells and promote neovascularization. In addition, EPCs are a promising cell …

Recent evidences suggest that endothelial progenitor cells (EPCs) derived from bone
marrow (BM) contribute to de novo vessel formation in adults occurring as physiological and …

Stem cells of various origins, particularly endothelial progenitor cells (EPCs), have potential
to enhance bone repair and regeneration. EPCs are resident in the bone marrow and home …

Endothelial progenitor cells (EPCs) promote new blood vessel formation and increase
angiogenesis by secreting growth factors and cytokines in ischemic tissues. Therefore …

Inadequate blood supply frequently impedes the viability of tissue-engineered constructs in
the initial phase after implantation, and can lead to improper cell integration or cell death …

Circulating endothelial progenitor cells (EPCs), are believed to be home to sites of
neovascularization, contributing to vascular regeneration either directly via incorporation …

Endothelial progenitor cells (EPCs) participate in vascular healing during both acute injury
and chronic disease. The quantity and quality of circulating EPCs correlate inversely with the …

Accumulating evidence indicates the impact of endothelial progenitor cells (EPCs) in
vascular repair. In patients, the number of EPCs is negatively correlated with the severity of …

Endothelial progenitor cells (EPCs) are under investigation due to their association with
vascular injury. In response to chemotactic stimuli they are mobilized from bone‐marrow and …

Purpose The purpose of this article was to analyze the results of studies in the literature,
which evaluated the use of endothelial progenitor cells (EPCs) as a cell-based tissue …